50 results match your criteria: "MedStar Heart Institute[Affiliation]"
PLoS One
February 2015
Department of Internal Medicine, Catholic University Medical School, Rome, Italy.
Objective: To investigate the effects of TLR4 antagonism on human endothelial cells activation and cytokine expression, and whether the Asp299Gly TLR4 polymorphism is associated with better endothelial function in patients with rheumatoid arthritis (RA).
Methods: Human aortic endothelial cells (HAECs) were treated with lipopolysaccharide (LPS), OxPAPC, and free fatty acids (FFA) at baseline and after incubation with the TLR4 antagonist eritoran (E5564). Cytokine expression was assessed by quantitative real-time PCR.
Eur Heart J Acute Cardiovasc Care
February 2015
Westchester Medical Center, New York Medical College, USA.
Background: Current diagnostic criteria for cardiogenic shock (CS) require the use of a pulmonary artery catheter (PAC), which is time-consuming and may cause complications. A set of simple yet accurate noninvasive diagnostic criteria would be of significant utility.
Methods: Candidate components for the Noninvasive Parameters for Assessment of Cardiogenic Shock (N-PACS) criteria were required to be objective, readily available, and noninvasive.
J Cardiovasc Transl Res
June 2014
MedStar Cardiovascular Research Network, MedStar Heart Institute, MedStar Washington Hospital Center, 110 Irving St., NW, Suite 4B-1, Washington, DC, 20010, USA.
Percutaneous coronary intervention (PCI) has rapidly evolved over the past 30 years as technology has sought to improve clinical outcomes by addressing pathophysiologic complications arising from the intervention. Stents were designed to resolve the drawbacks of balloon angioplasty by providing radial support to prevent vessel recoil, by sealing coronary dissections, and by preventing abrupt vessel closure. The conceptualization of an ideal drug-eluting fully bioresorbable scaffold (BRS), whether metallic or polymeric, would theoretically address the adverse aspects of permanent metallic stents.
View Article and Find Full Text PDFAtherosclerosis
June 2014
Westchester Medical Center, 100 Woods Road, Macy Pavilion, Room 102, Valhalla, NY, USA.
Objectives: This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.
Methods: We conducted a single center, randomized, double-blind, placebo controlled, cross-over trial in 80 patients with either hypertension or hypercholesterolemia and further classified as insulin-sensitive or insulin-resistant based on a published insulin sensitivity index. Participants received pioglitazone 45 mg daily or matching placebo for eight weeks.
Cardiovasc Revasc Med
April 2014
MedStar Cardiovascular Research Network, MedStar Heart Institute, Medstar Washington Hospital Center, Washington, DC, USA.
Am J Cardiol
May 2014
MedStar Heart Institute, Medstar Washington Hospital Center, MedStar Cardiovascular Research Network, Washington, District of Columbia. Electronic address:
Multiple studies have evaluated copeptin, a surrogate for arginine vasopressin, in the diagnosis of acute myocardial infarction (AMI) with mixed results. A systematic review and collaborative meta-analysis were performed for diagnosis of AMI and assessment of prognosis in patients presenting to the emergency department with chest pain. MEDLINE/PubMed, Cochrane CENTRAL, and EMBASE were searched for studies assessing copeptin in such patients.
View Article and Find Full Text PDFJ Cardiovasc Pharmacol
April 2014
*MedStar Cardiovascular Research Network, MedStar Heart Institute, Medstar Washington Hospital Center, Washington, DC; and †Departamento Ciencias Biomédicas, Universidad CEU Cardenal Herrera, Valencia, Spain.
The NLRP3 inflammasome has been shown to modulate IL-1B and IL-18 production, both key molecular regulators of inflammation. This editorial discusses a new molecule 16673-34-0 that inhibits the NLRP3 inflammasome and decreases caspase 1 production following ischemia reperfusion or acute peritonitis in mice.
View Article and Find Full Text PDFCardiovasc Revasc Med
April 2014
MedStar Heart Institute, MedStar Washington Hospital Center, Washington DC. Electronic address:
Introduction: The intra-aortic balloon pump (IABP) is the most frequently utilized form of temporary mechanical circulatory support (MCS) in cardiogenic shock (CS). Withdrawal of IABP support may precipitate hemodynamic compromise such that IABP reinsertion is required. Data are scarce regarding the incidence and outcomes of patients undergoing IABP reinsertion in this setting.
View Article and Find Full Text PDFJACC Heart Fail
April 2013
The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts.
Objectives: The aim of this study was to explore the clinical utility of a commercially available centrifugal flow pump as a centrifugal flow-right ventricular support device (CF-RVSD) in patients with right ventricular failure (RVF).
Background: RVF is associated with high in-hospital mortality. Limited data regarding efficacy of the CF-RVSD for RVF exist.
Life Sci
November 2014
Internal Medicine, Catholic University Medical School, Rome, Italy. Electronic address:
Obesity, the metabolic syndrome (MetS), and type 2 diabetes (T2DM) are associated with heightened cardiovascular risk. Given the vasoconstrictor and proatherogenic properties of endothelin (ET)-1, increased ET-1 activity has been postulated to participate in the derangement of adiposity-related vascular homeostasis. This concept is supported by human studies using receptor antagonists to show that the activity of endogenous ET-1 is indeed enhanced in overweight and obesity, the MetS, and T2DM.
View Article and Find Full Text PDFJ Cardiothorac Vasc Anesth
August 2014
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Catheter Cardiovasc Interv
February 2015
Section of Interventional Cardiology, MedStar Heart Institute, MedStar Washington Hospital Center, Washington, District of Columbia.
Objective: This study aims to report the long-term outcomes after percutaneous coronary intervention (PCI) in human immunodeficiency virus (HIV+) patients.
Background: Sparse data exists regarding the risk of patients with HIV who undergo PCI.
Methods: Using a case-control design, we compared baseline characteristics, procedure-related outcomes, in-hospital, and 2-year clinical outcomes of 112 consecutive HIV+ patients versus 112 HIV- controls matched for age, gender, and diabetes mellitus who underwent PCI from April 2003 to September 2011.
J Cardiovasc Comput Tomogr
October 2014
Department of Medicine, Medstar Georgetown University Hospital, Medstar Heart Institute, 3800 Reservoir Rd, NW, 5PHC, Washington, DC 20007, USA. Electronic address:
Aneurysms of the branches of the coronary arteries are rare. We report a case of a right coronary artery aneurysm with aneurysmal dilation and thrombosis of the sinoatrial nodal branch presenting as a right atrial mass. The patient underwent multiple imaging evaluations before coronary CT angiography diagnosed aneurysm and thrombosis of the sinoatrial nodal branch.
View Article and Find Full Text PDFJ Am Coll Cardiol
April 2014
Medstar Heart Institute, Washington Hospital Center, Washington, DC.
Int J Endocrinol
February 2014
MedStar Heart Institute and MedStar Cardiovascular Research Network, Washington, DC 20009, USA.
Int J Cardiol
November 2014
The Medstar Heart Institute, Washington, DC, USA; Medstar Washington Hospital Center, Washington, DC, USA; Medstar Georgetown University Hospital, Washington, DC, USA.
J Heart Lung Transplant
January 2014
Departments of Internal Medicine and Cardiac Surgery, MedStar Heart Institute, Washington, DC.
Background: The HeartWare left ventricular assist device (HVAD, HeartWare Inc, Framingham, MA) is the first implantable centrifugal continuous-flow pump approved for use as a bridge to transplantation. An infrequent but serious adverse event of LVAD support is thrombus ingestion or formation in the pump. In this study, we analyze the incidence of pump thrombus, evaluate the comparative effectiveness of various treatment strategies, and examine factors pre-disposing to the development of pump thrombus.
View Article and Find Full Text PDFJ Am Coll Cardiol
March 2014
MedStar Heart Institute, MedStar Washington Hospital Center, Washington, DC. Electronic address:
Crit Care Med
January 2014
1Surgical Critical Care Services, MedStar Washington Hospital Center, Washington, DC. 2Advanced Heart Failure Program, MedStar Heart Institute, MedStar Washington Hospital Center, Washington, DC.
Objectives: To review left ventricular assist device physiology, initial postoperative management, common complications, trouble shooting and management of hypotension, and other common ICU problems.
Data Source: Narrative review of relevant medical literature.
Data Synthesis: Left ventricular assist devices prolong the lives of patients with end-stage heart failure, and their use is increasing.
J Heart Valve Dis
July 2013
Medstar Heart Institute, Washington Hospital Center, 110 Irving St. NW, 1A-50B, Washington, DC 20010, USA.
The case is reported of a patient with a previously undiagnosed cause of severe congestive heart failure (CHF) caused by the presence of a discrete subaortic stenosis (SAS) from a subvalvular membrane (SVM). The clinical decision making was complicated by the concurrent presence of systolic anterior motion (SAM) of the mitral valve leaflet. Due to the limitations and eventual failure of physiologically opposing medical management strategies, the patient eventually required an open-heart surgical approach and underwent intraoperative SVM resection.
View Article and Find Full Text PDFCardiol Clin
November 2013
Coronary Care Unit, Medstar Heart Institute, Medstar Washington Hospital Center, 110 Irving Street Northwest, Suite NA-1103, Washington, DC 20010, USA. Electronic address:
Cardiogenic shock (CS) is a condition in which a marked reduction in cardiac output and inadequate end-organ perfusion results from an array of cardiac insults, the most common of which is acute myocardial infarction. CS is a systemic disease involving a vicious cycle of inflammation, ischemia, and progressive myocardial dysfunction, which often results in death. This life-threatening emergency requires intensive monitoring accompanied by aggressive hemodynamic support; other therapies are tailored to the specific pathophysiology.
View Article and Find Full Text PDFJ Am Coll Cardiol
March 2014
MedStar Washington Hospital Center and MedStar Heart Institute, Washington, DC. Electronic address:
JACC Cardiovasc Interv
October 2013
MedStar Cardiovascular Research Network, MedStar Heart Institute, MedStar Washington Hospital Center, Washington, DC. Electronic address:
One of the major dilemmas facing physicians is what diagnostic and therapeutic approaches should be recommended to those stable coronary artery disease patients whose symptoms are adequately controlled on medical therapy. This study sought to assess the evidence-based data relating to whether: 1) all patients with significant coronary lesions (i.e.
View Article and Find Full Text PDFSemin Thorac Cardiovasc Surg
March 2014
Advanced Heart Failure and Transplant Program, Department of Cardiac Surgery, MedStar Heart Institute, MedStar Washington Hospital Center, Washington, DC 20010, USA.
The use of long-term left ventricular assist devices (LVADs) has revolutionized the treatment of end-stage heart failure. The most significant advance in this field has been the longer durability of devices secondary to a simpler pump design with fewer or no mechanical bearings and valves. Continuous-flow LVADs have recently been shown to provide safe and effective circulatory support and have replaced the first-generation fill-to-empty devices.
View Article and Find Full Text PDFProg Cardiovasc Dis
May 2013
Medstar Heart Institute, Medstar Georgetown University Hospital, Washington, DC 20007, USA.
The Surgical Treatment for Ischemic Heart Failure (STICH) trial found that viability assessment did not identify patients with a survival advantage from coronary artery bypass grafting (CABG) compared to medical therapy. STICH viability testing was performed with single-photon emission computed tomography (SPECT) myocardial perfusion imaging, dobutamine echocardiography, or both. There has been controversy regarding the strength of the conclusions, and whether newer technologies such as cardiac magnetic resonance (CMR) or position emission tomography imaging (PET) would have changed the results.
View Article and Find Full Text PDF